Hardly much of a dip. Less than 10% down on the SPP price. I think what we have here are some opportunistic holders recovering some capital to partake in the SPP for the options.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025